Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05147389 · ClinicalTrials.gov registry record
Artificial Intelligence for Digital Cholangioscopy Neoplasia Diagnosis
A clinical trial of Common Bile Duct Neoplasms and Non-Neoplastic Bile Duct Disorder, sponsored by Instituto Ecuatoriano de Enfermedades Digestivas.
- Completed
- Registry status
- 170
- Enrollment target
- 6
- Study locations
NCT05147389 is a study of Common Bile Duct Neoplasms and Non-Neoplastic Bile Duct Disorder that has completed, run by Instituto Ecuatoriano de Enfermedades Digestivas. The registered enrollment target is 170 participants. The trial reports 6 study locations across 4 states.
The verdict
NCT05147389, a study of Common Bile Duct Neoplasms and Non-Neoplastic Bile Duct Disorder, has completed, sponsored by Instituto Ecuatoriano de Enfermedades Digestivas.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
- 6
- Study locations
Study Summary
Digital single-operator cholangioscopy (DSOC) findings achieve high diagnostic accuracy for neoplastic bile duct lesions. To date, there is not a universally accepted DSOC classification. Endoscopists' Intra and interobserver agreements vary widely. Cholangiocarcinoma (CCA) assessment through artificial intelligence (AI) tools is almost exclusively for intrahepatic CCA (iCCA). Therefore, more AI tools are necessary for assessing extrahepatic neoplastic bile duct lesions. In Ecuador, the investigators have recently proposed an AI model to classify bile duct lesions during real-time DSOC, which accurately detected malignancy patterns. This research pursues a clinical validation of our AI model for distinguishing between neoplastic and non-neoplastic bile duct lesions, compared with high DSOC experienced endoscopists.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST AI model classification
- DIAGNOSTIC_TEST DSOC endoscopist experts' classification
Study Locations (6)
Texas
- Baylor Saint Luke's Medical Center - Houston
- Houston Methodist Hospital - Houston
Other
- Department of Advanced Interventional Endoscopy, Universitair Ziekenhuis Brussel (UZB)/Vrije Universiteit Brussel (VUB) - Brussels
- Serviço de Endoscopía Gastrointestinal do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - São Paulo
New Jersey
- Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University - New Brunswick
Guayas
- Carlos Robles-Medranda - Guayaquil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2022-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05147389
The ClinicalTrials.gov registry entry for NCT05147389 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Instituto Ecuatoriano de Enfermedades Digestivas, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Common Bile Duct Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which AI model classification is the first listed.
NCT05147389 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Texas, Other, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05147389 about?
NCT05147389 is a clinical study titled "Artificial Intelligence for Digital Cholangioscopy Neoplasia Diagnosis". Digital single-operator cholangioscopy (DSOC) findings achieve high diagnostic accuracy for neoplastic bile duct lesions. To date, there is not a universally accepted DSOC classification. Endoscopists' Intra and interobserver agreements vary widely. Cholangiocarcinoma (CCA) assessment through artifi...
What is the current status of trial NCT05147389?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2020-10-01. Estimated completion is 2022-05-01.
What conditions does trial NCT05147389 study?
This clinical trial studies the following conditions: Common Bile Duct Neoplasms, Non-Neoplastic Bile Duct Disorder.
What interventions are being tested in trial NCT05147389?
The interventions under investigation include: AI model classification (DIAGNOSTIC_TEST), DSOC endoscopist experts' classification (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05147389?
This trial is sponsored by Instituto Ecuatoriano de Enfermedades Digestivas, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05147389 being conducted?
This trial has 6 study locations across New Jersey, Texas, Guayas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Common Bile Duct Neoplasms
All registered trials for this condition
Non-Neoplastic Bile Duct Disorder
All registered trials for this condition
New Jersey
All trials with a study site in New Jersey
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.